SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hikal informs about press release

10 Jun 2026 Evaluate
Hikal has informed that it enclosed copies of the newspaper publication published in Business Standard and Mumbai Lakshadeep on June 10, 2026, informing the shareholders about opening of Special Window for transfer, in accordance with SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/ I/3750/2026 dated January 30, 2026. This intimation is also being made available on the website of the Company www.hikal.com

The above information is a part of company’s filings submitted to BSE.

Hikal Share Price

176.90 -1.10 (-0.62%)
11-Jun-2026 09:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1787.35
Dr. Reddys Lab 1277.60
Cipla 1377.10
Zydus Lifesciences 1100.35
Lupin 2261.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×